Cargando…
Factors affecting the uptake of preventive chemotherapy treatment for schistosomiasis in Sub-Saharan Africa: A systematic review
BACKGROUND: Schistosomiasis affects nearly 220 million people worldwide, mainly in Sub-Saharan Africa (SSA). Preventive chemotherapy (PC) treatment, through regular mass-drug administration (MDA) of Praziquantel tablets remains the control measure of choice by Ministries of Health. Current guideline...
Autores principales: | Torres-Vitolas, Carlos A., Dhanani, Neerav, Fleming, Fiona M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846123/ https://www.ncbi.nlm.nih.gov/pubmed/33465076 http://dx.doi.org/10.1371/journal.pntd.0009017 |
Ejemplares similares
-
Impact of human schistosomiasis in sub-Saharan Africa
por: Adenowo, Abiola Fatimah, et al.
Publicado: (2015) -
Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study
por: Kokaliaris, Christos, et al.
Publicado: (2022) -
Knowledge, attitudes and practices on Schistosomiasis in sub-Saharan Africa: a systematic review
por: Sacolo, Hlengiwe, et al.
Publicado: (2018) -
Rethinking the Top-Down Approach to Schistosomiasis Control and Elimination in Sub-Saharan Africa
por: Onasanya, Adeola, et al.
Publicado: (2021) -
Parasite Population Genetic Contributions to the Schistosomiasis Consortium for Operational Research and Evaluation within Sub-Saharan Africa
por: Webster, Joanne P., et al.
Publicado: (2020)